These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 21613828)

  • 1. Combination of ultrasound and bubble liposome enhance the effect of doxorubicin and inhibit murine osteosarcoma growth.
    Ueno Y; Sonoda S; Suzuki R; Yokouchi M; Kawasoe Y; Tachibana K; Maruyama K; Sakamoto T; Komiya S
    Cancer Biol Ther; 2011 Aug; 12(4):270-7. PubMed ID: 21613828
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Using acoustic cavitation to enhance chemotherapy of DOX liposomes: experiment in vitro and in vivo.
    Zhao YZ; Dai DD; Lu CT; Lv HF; Zhang Y; Li X; Li WF; Wu Y; Jiang L; Li XK; Huang PT; Chen LJ; Lin M
    Drug Dev Ind Pharm; 2012 Sep; 38(9):1090-8. PubMed ID: 22188116
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Self-assembled liposome-loaded microbubbles: The missing link for safe and efficient ultrasound triggered drug-delivery.
    Geers B; Lentacker I; Sanders NN; Demeester J; Meairs S; De Smedt SC
    J Control Release; 2011 Jun; 152(2):249-56. PubMed ID: 21362448
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sequential HIFU heating and nanobubble encapsulation provide efficient drug penetration from stealth and temperature sensitive liposomes in colon cancer.
    VanOsdol J; Ektate K; Ramasamy S; Maples D; Collins W; Malayer J; Ranjan A
    J Control Release; 2017 Feb; 247():55-63. PubMed ID: 28042085
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Estrogen-functionalized liposomes grafted with glutathione-responsive sheddable chotooligosaccharides for the therapy of osteosarcoma.
    Yin X; Feng S; Chi Y; Liu J; Sun K; Guo C; Wu Z
    Drug Deliv; 2018 Nov; 25(1):900-908. PubMed ID: 29644882
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hyaluronated liposomes containing H2S-releasing doxorubicin are effective against P-glycoprotein-positive/doxorubicin-resistant osteosarcoma cells and xenografts.
    Gazzano E; Buondonno I; Marengo A; Rolando B; Chegaev K; Kopecka J; Saponara S; Sorge M; Hattinger CM; Gasco A; Fruttero R; Brancaccio M; Serra M; Stella B; Fattal E; Arpicco S; Riganti C
    Cancer Lett; 2019 Aug; 456():29-39. PubMed ID: 31047947
    [TBL] [Abstract][Full Text] [Related]  

  • 7. EphA2 Targeted Doxorubicin-Nanoliposomes for Osteosarcoma Treatment.
    Haghiralsadat F; Amoabediny G; Naderinezhad S; Nazmi K; De Boer JP; Zandieh-Doulabi B; Forouzanfar T; Helder MN
    Pharm Res; 2017 Dec; 34(12):2891-2900. PubMed ID: 29110283
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Redox-sensitive and hyaluronic acid functionalized liposomes for cytoplasmic drug delivery to osteosarcoma in animal models.
    Chi Y; Yin X; Sun K; Feng S; Liu J; Chen D; Guo C; Wu Z
    J Control Release; 2017 Sep; 261():113-125. PubMed ID: 28666726
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The antitumor activity of tumor-homing peptide-modified thermosensitive liposomes containing doxorubicin on MCF-7/ADR: in vitro and in vivo.
    Wang C; Wang X; Zhong T; Zhao Y; Zhang WQ; Ren W; Huang D; Zhang S; Guo Y; Yao X; Tang YQ; Zhang X; Zhang Q
    Int J Nanomedicine; 2015; 10():2229-48. PubMed ID: 25834435
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Doxorubicin liposome-loaded microbubbles for contrast imaging and ultrasound-triggered drug delivery.
    Escoffre JM; Mannaris C; Geers B; Novell A; Lentacker I; Averkiou M; Bouakaz A
    IEEE Trans Ultrason Ferroelectr Freq Control; 2013 Jan; 60(1):78-87. PubMed ID: 23287915
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Design and evaluation of doxorubicin-containing microbubbles for ultrasound-triggered doxorubicin delivery: cytotoxicity and mechanisms involved.
    Lentacker I; Geers B; Demeester J; De Smedt SC; Sanders NN
    Mol Ther; 2010 Jan; 18(1):101-8. PubMed ID: 19623162
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Focused ultrasound and interleukin-4 receptor-targeted liposomal doxorubicin for enhanced targeted drug delivery and antitumor effect in glioblastoma multiforme.
    Yang FY; Wong TT; Teng MC; Liu RS; Lu M; Liang HF; Wei MC
    J Control Release; 2012 Jun; 160(3):652-8. PubMed ID: 22405901
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hyaluronic acid modified pH-sensitive liposomes for targeted intracellular delivery of doxorubicin.
    Paliwal SR; Paliwal R; Agrawal GP; Vyas SP
    J Liposome Res; 2016 Dec; 26(4):276-87. PubMed ID: 26784587
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of prostate cancer growth using doxorubicin assisted by ultrasound-targeted nanobubble destruction.
    Fan X; Wang L; Guo Y; Xiong X; Zhu L; Fang K
    Int J Nanomedicine; 2016; 11():3585-96. PubMed ID: 27536100
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel temperature-triggered liposome with high stability: formulation, in vitro evaluation, and in vivo study combined with high-intensity focused ultrasound (HIFU).
    Park SM; Kim MS; Park SJ; Park ES; Choi KS; Kim YS; Kim HR
    J Control Release; 2013 Sep; 170(3):373-9. PubMed ID: 23770213
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activation of microbubbles by low-level therapeutic ultrasound enhances the antitumor effects of doxorubicin.
    Yang S; Wang P; Wang X; Su X; Liu Q
    Eur Radiol; 2014 Nov; 24(11):2739-53. PubMed ID: 25097127
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Cellular toxicity and anti-tumor efficacy of iRGD modified doxorubixin loaded sterically stabilized liposomes].
    Zhao B; Fan YC; Wang XQ; Dai WB; Zhang Q; Wang XL
    Yao Xue Xue Bao; 2013 Mar; 48(3):417-22. PubMed ID: 23724658
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Co-delivery of doxorubicin and plasmid by a novel FGFR-mediated cationic liposome.
    Xiao W; Chen X; Yang L; Mao Y; Wei Y; Chen L
    Int J Pharm; 2010 Jun; 393(1-2):119-26. PubMed ID: 20416367
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A comparative study of folate receptor-targeted doxorubicin delivery systems: dosing regimens and therapeutic index.
    Scomparin A; Salmaso S; Eldar-Boock A; Ben-Shushan D; Ferber S; Tiram G; Shmeeda H; Landa-Rouben N; Leor J; Caliceti P; Gabizon A; Satchi-Fainaro R
    J Control Release; 2015 Jun; 208():106-20. PubMed ID: 25869964
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mild hyperthermia triggered doxorubicin release from optimized stealth thermosensitive liposomes improves intratumoral drug delivery and efficacy.
    Li L; ten Hagen TL; Hossann M; Süss R; van Rhoon GC; Eggermont AM; Haemmerich D; Koning GA
    J Control Release; 2013 Jun; 168(2):142-50. PubMed ID: 23524188
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.